Australia's most trusted
source of pharma news
Wednesday, 20 August 2025
Posted 20 August 2025 AM
Boehringer Ingelheim has announced a change in leadership for its ANZ animal health business with Christoph Tautphäus promoted to a regional role overseeing both human pharma and animal health.
Tautphäus will commence as Finance and Administration Director for the Regional Operating Unit Mid-Sized European Countries, based in Amsterdam, from 1 October.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.